
Moderna’ Stock Rises 12% as Covid-19 Vaccine Advances to Trial on 30,000 People
Moderna announced on Monday that it had started the first phase III study of a vaccine in the US. The
Moderna announced on Monday that it had started the first phase III study of a vaccine in the US. The
Get notified about new articles